Rubi Laboratories

Rubi LaboratoriesRubi Laboratories
Rubi Laboratories

Rubi Laboratories

Turning CO2 into cellulose for textiles using an innovative, carbon-negative enzymatic process.

Website
2021Active
Rate
Advertise here

About

Rubi Laboratories is a biotechnology startup that has developed a proprietary, cell-free biocatalytic process to convert carbon dioxide (CO2) into cellulose. This cellulose serves as a sustainable, carbon-negative alternative to wood pulp for the textile industry, enabling brands to produce lyocell and viscose fibers without contributing to deforestation or high water and land usage.

Technology stack

detected 2026-07-04
CDN
Cloudflare
EmailMicrosoft 365
Stack
Webflow
Analytics
Microsoft ClarityMatomo
Email marketing
Mailchimp
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Rubi Laboratories do?

Rubi Laboratories is a biotechnology startup that has developed a proprietary, cell-free biocatalytic process to convert carbon dioxide (CO2) into cellulose. This cellulose serves as a sustainable, carbon-negative alternative to wood pulp for the textile industry, enabling brands to produce lyocell and viscose fibers without contributing to deforestation or high water and land usage.

How much funding has Rubi Laboratories raised?

Rubi Laboratories has raised a total of $5M in funding. The most recent round on record is Seed.

Where is Rubi Laboratories headquartered?

Rubi Laboratories is headquartered in San Francisco, United States.

When was Rubi Laboratories founded?

Rubi Laboratories was founded in 2021.

What industry does Rubi Laboratories operate in?

Rubi Laboratories operates in Biotechnology, Materials Science, Sustainability, Textiles, Clean Technology.

What is Rubi Laboratories's revenue?

StartupHub estimates Rubi Laboratories's annual revenue at $80.3M (range $37.9M to $136.2M, 44% confidence), based on comparable companies in the sector.

What is Rubi Laboratories's valuation?

StartupHub estimates Rubi Laboratories's effective valuation at $624.1M (range $436.8M to $811.3M, 28% confidence), based on comparable companies in the sector.